Windacre Partnership Has Cut Its Stake in Santander Consumer Usa Hdg I (SC) by $1.19 Million; Corcept Therapeutics (CORT) Shareholder Consonance Capital Management LP Cut Its Stake as Stock Rose

January 19, 2018 - By Marie Mckinney

Mitchell Blutt decreased its stake in Corcept Therapeutics Inc (CORT) by 33.12% based on its latest 2017Q3 regulatory filing with the SEC. Consonance Capital Management Lp sold 1.92 million shares as the company’s stock rose 42.01% with the market. The hedge fund run by Mitchell Blutt held 3.88M shares of the major pharmaceuticals company at the end of 2017Q3, valued at $74.93 million, down from 5.80M at the end of the previous reported quarter. Consonance Capital Management Lp who had been investing in Corcept Therapeutics Inc for a number of months, seems to be less bullish one the $2.69B market cap company. The stock increased 6.26% or $1.39 during the last trading session, reaching $23.58. About 3.12 million shares traded or 73.43% up from the average. Corcept Therapeutics Incorporated (NASDAQ:CORT) has risen 124.81% since January 19, 2017 and is uptrending. It has outperformed by 108.11% the S&P500.

Windacre Partnership Llc decreased its stake in Santander Consumer Usa Hdg I (SC) by 0.63% based on its latest 2017Q3 regulatory filing with the SEC. Windacre Partnership Llc sold 79,200 shares as the company’s stock declined 16.81% while stock markets rallied. The institutional investor held 12.58M shares of the consumer services company at the end of 2017Q3, valued at $193.43 million, down from 12.66 million at the end of the previous reported quarter. Windacre Partnership Llc who had been investing in Santander Consumer Usa Hdg I for a number of months, seems to be less bullish one the $6.52B market cap company. The stock decreased 0.44% or $0.08 during the last trading session, reaching $18.12. About 2.34 million shares traded or 28.64% up from the average. Santander Consumer USA Holdings Inc. (NYSE:SC) has risen 1.54% since January 19, 2017 and is uptrending. It has underperformed by 15.16% the S&P500.

Among 23 analysts covering Santander Consumer USA Holdings (NYSE:SC), 12 have Buy rating, 0 Sell and 11 Hold. Therefore 52% are positive. Santander Consumer USA Holdings had 58 analyst reports since August 3, 2015 according to SRatingsIntel. The stock of Santander Consumer USA Holdings Inc. (NYSE:SC) earned “Buy” rating by Susquehanna on Thursday, January 4. The company was maintained on Friday, July 28 by BMO Capital Markets. On Friday, January 12 the stock rating was upgraded by J.P. Morgan to “Buy”. Stephens maintained Santander Consumer USA Holdings Inc. (NYSE:SC) rating on Wednesday, January 3. Stephens has “Hold” rating and $23.0 target. The rating was maintained by Keefe Bruyette & Woods on Tuesday, November 14 with “Hold”. The firm earned “Overweight” rating on Friday, January 12 by JP Morgan. On Wednesday, March 16 the stock rating was downgraded by JMP Securities to “Market Perform”. The firm has “Hold” rating by Keefe Bruyette & Woods given on Thursday, December 21. The firm has “Neutral” rating by Compass Point given on Thursday, April 28. Compass Point upgraded Santander Consumer USA Holdings Inc. (NYSE:SC) on Thursday, April 27 to “Buy” rating.

Investors sentiment decreased to 1.18 in 2017 Q3. Its down 0.35, from 1.53 in 2017Q2. It dived, as 25 investors sold SC shares while 42 reduced holdings. 29 funds opened positions while 50 raised stakes. 113.25 million shares or 0.98% more from 112.15 million shares in 2017Q2 were reported. Gsa Prtn Llp reported 121,055 shares. Wells Fargo & Mn has invested 0.01% in Santander Consumer USA Holdings Inc. (NYSE:SC). Legal General Public Limited Com stated it has 0.01% in Santander Consumer USA Holdings Inc. (NYSE:SC). Credit Suisse Ag has 3.19 million shares. Canada Pension Plan Board accumulated 189,600 shares or 0.01% of the stock. Employees Retirement Association Of Colorado has 4,647 shares for 0% of their portfolio. 74,137 are held by Aviva Public Limited Company. New York State Common Retirement Fund has invested 0.02% in Santander Consumer USA Holdings Inc. (NYSE:SC). Brandywine Glob Investment Management Ltd Company has invested 0.53% of its portfolio in Santander Consumer USA Holdings Inc. (NYSE:SC). Castine Mgmt Limited Liability Corporation invested 1.82% of its portfolio in Santander Consumer USA Holdings Inc. (NYSE:SC). Proxima Mgmt Ltd Limited Liability Company invested 3.35% in Santander Consumer USA Holdings Inc. (NYSE:SC). Numeric Lc has invested 0% in Santander Consumer USA Holdings Inc. (NYSE:SC). Bank Of Montreal Can reported 0% of its portfolio in Santander Consumer USA Holdings Inc. (NYSE:SC). Carlson Capital Lp invested 2.11% in Santander Consumer USA Holdings Inc. (NYSE:SC). Fuller Thaler Asset has 0% invested in Santander Consumer USA Holdings Inc. (NYSE:SC) for 7,900 shares.

Analysts await Santander Consumer USA Holdings Inc. (NYSE:SC) to report earnings on January, 31 before the open. They expect $0.32 earnings per share, up 88.24% or $0.15 from last year’s $0.17 per share. SC’s profit will be $115.18M for 14.16 P/E if the $0.32 EPS becomes a reality. After $0.48 actual earnings per share reported by Santander Consumer USA Holdings Inc. for the previous quarter, Wall Street now forecasts -33.33% negative EPS growth.

Consonance Capital Management Lp, which manages about $513.80 million and $904.16 million US Long portfolio, upped its stake in Pacific Biosciences Calif In (NASDAQ:PACB) by 3.07 million shares to 6.90 million shares, valued at $36.23 million in 2017Q3, according to the filing.

Since December 8, 2017, it had 0 insider purchases, and 2 selling transactions for $283,125 activity.

Investors sentiment decreased to 1.96 in Q3 2017. Its down 0.47, from 2.43 in 2017Q2. It fall, as 13 investors sold CORT shares while 39 reduced holdings. 47 funds opened positions while 55 raised stakes. 71.96 million shares or 6.38% more from 67.64 million shares in 2017Q2 were reported. California-based Menta Cap Ltd Llc has invested 0.19% in Corcept Therapeutics Incorporated (NASDAQ:CORT). Wealth Architects Ltd reported 0.11% of its portfolio in Corcept Therapeutics Incorporated (NASDAQ:CORT). California Public Employees Retirement reported 162,459 shares. Alliancebernstein Lp invested 0% of its portfolio in Corcept Therapeutics Incorporated (NASDAQ:CORT). Usa Fincl Portformulas owns 34,091 shares. Buckingham Asset Mngmt Ltd Llc invested in 20,000 shares or 0.09% of the stock. Prudential Fin stated it has 1.10M shares. Ameriprise invested in 0% or 301,695 shares. Deutsche Bancorporation Ag owns 219,703 shares. James Invest Research stated it has 117,400 shares. Moreover, Blume Capital Management has 0.01% invested in Corcept Therapeutics Incorporated (NASDAQ:CORT). Mckinley Capital Limited Liability Corporation Delaware stated it has 308,607 shares. Caxton Assocs LP has invested 0.01% of its portfolio in Corcept Therapeutics Incorporated (NASDAQ:CORT). Nationwide Fund holds 50,615 shares. Tci Wealth Advsr reported 0% in Corcept Therapeutics Incorporated (NASDAQ:CORT).

Among 4 analysts covering Corcept Therapeutics (NASDAQ:CORT), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Corcept Therapeutics had 7 analyst reports since February 2, 2017 according to SRatingsIntel. Ladenburg Thalmann initiated the shares of CORT in report on Thursday, February 2 with “Buy” rating. On Wednesday, October 11 the stock rating was maintained by Piper Jaffray with “Buy”. The company was maintained on Friday, September 8 by Piper Jaffray. As per Thursday, August 24, the company rating was maintained by Piper Jaffray. The firm has “Buy” rating by Stifel Nicolaus given on Friday, November 3.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.